Federal Register / Vol. 87, No. 101 / Wednesday, May 25, 2022 / Notices 31895 

4NCVHS Listening Session on Healthcare 

Standards Development, Adoption and 

Implementation, Aug. 25, 2021. Agenda, audio 

recording, transcript, and other meeting materials 

are available at: https://ncvhs.hhs.gov/meetings/ 

standards-subcommittee-listening-session/. 

5ONC, Ofc. of the Sec’y, U.S. Dept. of Health & 

Human Services, 2020–2025 Federal Health IT 

Strategic Plan (Oct. 2020), available at https://

www.healthit.gov/topic/2020-2025-federal-health-itstrategic-plan. 

6See U.S. Dept. of Health & Human Svcs., 

NCVHS, Notice of Meeting and Request for Public 

Comment, 86 FR 33318 (June 24, 2021), available 

at https://www.govinfo.gov/content/pkg/FR-2021- 

06-24/pdf/2021-13334.pdf; ‘‘Comments Received in 

Response to Request for Comment: Federal Register 

Notice: 86 FR 33318,’’ available at https://

ncvhs.hhs.gov/wp-content/uploads/2021/08/PublicComments-Standards-Subcommittee-ListeningSession-August-25-2021.pdf. 

stage for future directions toward the 

strategic vision. 

The Subcommittee on Standards 

drafted a suite of potential actions for 

consideration for near-term 

improvement of the current standards 

development and rulemaking processes 

informed by the August 21, 2021, 

Listening Session.4 The Committee is 

seeking reaction to this draft set of 

actions from potential end-users, 

standards development organizations 

(SDOs), trade and professional 

organizations, and other members of the 

public. The purpose of this meeting is 

to provide a public forum to obtain this 

feedback. Based on that input, the 

Subcommittee anticipates developing 

recommendations for consideration by 

the full Committee. The draft 

considerations and supporting context 

may be viewed on the NCVHS website 

at https://ncvhs.hhs.gov/DraftConvergence-2-dot-0. 

Summary 

Subtitle F (Administrative 

Simplification) of HIPAA promoted the 

transition of routine business processes 

of health care from mailing and faxing 

of paper documents to electronic 

exchange of standardized data. Health 

data flows, standards, technology, and 

communications infrastructure have all 

evolved radically since HIPAA 

introduced the concept of national 

standards to health care administration. 

Consistent with the Office of the 

National Coordinator for Health 

Information Technology’s (ONC) 

Federal Health Information Technology 

Strategic Plan,5 the Subcommittee is 

investigating what would be necessary 

to prepare the U.S. health care system 

for its next leap forward. The 

Subcommittee is proposing for industry 

feedback actions to further a 

comprehensive, integrated health 

information ecosystem that incorporates 

claims, administrative records, digital 

medical records, public health data, and 

data about a patient’s social risk. These 

proposed actions include specific 

updating of standardization processes 

under HIPAA to accommodate new 

business models, technologies, and 

information needs, while protecting 

investments in legacy standards that 

have demonstrably succeeded in 

producing HIPAA’s intended 

efficiencies and cost reductions. 

As noted above, to inform this 

rethinking and updating, NCVHS’ 

Convergence 2.0 project solicited input 

from industry on the HIPAA regulatory 

framework and the standards update 

processes in a public Listening Session 

on August 25, 2021. During the 

Listening Session, representatives of 

industry testified that current processes 

do not fit with the cadence needed to 

meet their business needs. They further 

advocated that options and alternatives 

for a modernized framework should be 

considered to support current and 

future needs, including additional 

harmonization of clinical, public health 

(including vital records), and other 

standards with HIPAA standards. The 

implication is that options or 

alternatives would need to consider 

significant portions of work done by 

ONC and its Health Information 

Technology Advisory Committee on 

electronic health records, data exchange 

networks, and an interoperability 

framework. 

Based on its analysis of the input of 

expert panels and members of the 

public who responded to a Request for 

Public Comment,6 the Committee 

continues to investigate whether the 

HIPAA framework is in need of 

modernization. 

The Committee will invite statements 

from representatives of stakeholder 

organizations, and the agenda also will 

include time for public comment. 

Meeting times and topics are subject to 

change. Please refer to the agenda 

posted at the NCVHS website for this 

meeting for updates at: https://

ncvhs.hhs.gov/meetings/standardssubcommittee-meeting-3/. 

Sharon Arnold, 

Associate Deputy Assistant Secretary, Science 

and Data Policy, Office of the Assistant 

Secretary for Planning and Evaluation. 

[FR Doc. 2022–11251 Filed 5–24–22; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group; Microbiology and Infectious Diseases 

Research Study Section Microbiology and 

Infectious Diseases Research Study Section. 

Date: June 16–17, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3F40A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Robert C. Unfer, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3F40A, Rockville, MD 

20852, (240) 669–5035, robert.unfer@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: May 19, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–11220 Filed 5–24–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 


lotter on DSK11XQN23PROD with NOTICES1
31896 Federal Register / Vol. 87, No. 101 / Wednesday, May 25, 2022 / Notices 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Identification and 

Characterization of Persistence Mechanisms 

of Select Protozoan Pathogens (R01 Clinical 

Trials Not Allowed). 

Date: June 21–22, 2022. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3F36, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Noton K. Dutta, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3F36, Rockville, MD 

20852, 240–669–2857, noton.dutta@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: May 19, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–11219 Filed 5–24–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; National Institutes of Health 

(NIH) Loan Repayment Programs, 

(Office of the Director) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995 to provide 

opportunity for public comment on 

proposed data collection projects, the 

NIH will publish periodic summaries of 

proposed projects to be submitted to the 

Office of Management and Budget 

(OMB) for review and approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Matthew Lockhart, Acting 

Director, Division of Loan Repayment 

(DLR), National Institutes of Health, 

6700B Rockledge Dr., Room 2300 (MSC 

6904), Bethesda, Maryland 20892–6904 

or email your request, including your 

address to: matthew.lockhart@nih.gov or 

call (240) 380–3062. Formal requests for 

additional plans and instruments must 

be requested in writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimizes 

the burden of the collection of 

information on those who are to 

respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Proposed Collection Title: National 

Institutes of Health (NIH) Loan 

Repayment Programs (LRP), 0925–0361, 

expiration date 10/31/2022, 

EXTENSION, Office of the Director 

(OD), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: The NIH makes available 

financial assistance, in the form of 

educational loan repayment, to M.D., 

Ph.D., Pharm.D., Psy.D., D.O., D.D.S., 

D.M.D., D.P.M., DC, N.D., O.D., D.V.M, 

or equivalent doctoral degree holders 

who perform biomedical or behavioral 

research in NIH intramural laboratories 

or as extramural grantees or scientists 

funded by domestic non-profit 

organizations for a minimum of two 

years (three years for the General 

Research subcategory) in research areas 

supporting the mission and priorities of 

the NIH. The information proposed for 

collection will be used by the DLR to 

determine an applicant’s eligibility for 

the program. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

23,952. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average time 

per response 

(in hours) 

Total annual 

burden hours 

Initial Extramural Applicants ............................................................................ 1,300 1 8 10,400 

Renewal Extramural Applicants ....................................................................... 1,000 1 8 8,000 

Initial Intramural Applicants ............................................................................. 40 1 8 320 

Renewal Intramural Applicants ........................................................................ 40 1 8 320 

Recommenders ................................................................................................ 9,360 1 30/60 4,680

Institutional Contacts ....................................................................................... 2,300 1 5/60 192 

NIH LRP Coordinators ..................................................................................... 80 1 30/60 40 

Total .......................................................................................................... 14,120 14,120 ........................ 23,952 


lotter on DSK11XQN23PROD with NOTICES1